This is the largest rheumatoid arthritis prevention trial to date and the first to show that a therapy licensed for use in treating established rheumatoid arthritis may prevent the development of RA.' - Prof Andrew Cope
Researchers said the results, published in the Lancet, were promising and could be good news for people at risk of arthritis.
Collection
[
|
...
]